Vimarsana
Biggest News Aggregation in the World

Page 3 - Nasdaq Algs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Algs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Algs Today - Breaking & Trending Today

Amgen (NASDAQ:AMGN) vs. Aligos Therapeutics (NASDAQ:ALGS) Head to Head Contrast - Vimarsana News

Amgen (NASDAQ:AMGN) vs. Aligos Therapeutics (NASDAQ:ALGS) Head to Head Contrast

Aligos Therapeutics (NASDAQ:ALGS – Get Rating) and Amgen (NASDAQ:AMGN – Get Rating) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings and dividends. Volatility and Risk Aligos Therapeutics has a beta of 3.52, indicating […]

Cantor Fitzgerald Weighs in on Aligos Therapeutics, Inc.'s FY2022 Earnings (NASDAQ:ALGS) - Vimarsana News

Cantor Fitzgerald Weighs in on Aligos Therapeutics, Inc.'s FY2022 Earnings (NASDAQ:ALGS)

Aligos Therapeutics, Inc. (NASDAQ:ALGS – Get Rating) – Equities researchers at Cantor Fitzgerald issued their FY2022 EPS estimates for Aligos Therapeutics in a research report issued on Wednesday, March 16th. Cantor Fitzgerald analyst A. Young forecasts that the company will earn ($3.99) per share for the year. A number of other equities analysts have also […]

Aligos Therapeutics to Present Data for its Clinical - Vimarsana News

Aligos Therapeutics to Present Data for its Clinical

SOUTH SAN FRANCISCO, Calif., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company...